Rob Dillard

DocwireNews

Frailty remains a major problem for patients with amyloid transthyretin (ATTR) cardiac amyloidosis (ATTR-CA), according to a study being presented at the International Symposium on Amyloidosis 2024.
&#8220;From clinical experience and clinical trials, it is apparent that patients with ATTR-CA are being diagnosed earlier and with less severe disease than those seen a decade ago. Yet this remains a disease of aging. Hence, frailty is an important consideration in ATTR-CM,&#8221; the researchers noted.
In this study, the investigators assessed 116 patients with proven ATTR-CM. The subjects underwent the Short Performance Physical Battery (SPPB) and standard clinical evaluations, which consisted of a brief series of physical tests developed to analyze balance, gait speed, and unassisted standing from a chair. The SPPB is scored from 0 to 12, and a score of 8 or lower indicates frailty.
According to the results, 38.8% of patients had an SPPB score indicative of frailty. Patients with low SPPB scores had higher rates of atrial fibrillation/flutter or a paced rhythm (12/71 vs 22/45; P=.02) and higher NT-proBNP (median, 1170 [560-2459] pg/ml vs 1977 [970-3197] pg/ml; P=.024).
&#8220;In a population of patients with ATTR amyloidosis, frailty remains a substantial problem among a large minority of patients. We strongly recommend its assessment in all ATTR-CA. This can be easily achieved, in less than 10 minutes, using the easy-to-learn and simple-to-perform SPPB score,&#8221; the investigators concluded.

Balazs Halmos, MD

Dr. Balazs Halmos on Historic Lung Cancer Developments From the American Society of Clinical Oncology Annual Meeting

ASCO 2024: Focus on Lung Cancer

Rami Manochakian, MD, FASCO

Dr. Rami Manochakian Discusses Major Lung Cancer Updates

Advancements in Oncology

Nera Lopetegui-Lia, MD

Dr. Nerea Lopetegui-Lia on the Implications of DESTINY-Breast06 for Clinical Practice

Latest News

Frailty Is a Significant Problem for People With ATTR Cardiac Amyloidosis

ISA 2024

Frailty is an important consideration for patients with amyloid transthyretin cardiac amyloidosis, who are often elderly.

Frailty Is a Significant Problem in People With ATTR Cardiac Amyloidosis

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Onc Brothers Event

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Diabetes

Oncology

Neurology

Rheumatology

Gastroenterology

Pulmonology

Ophthalmology

Infectious Diseases

— HIV

Health and Wellness

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Fellow on Call

Healthcare Unfiltered

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Career Center

Expert Interviews

Subscribe